BioNTech SE (BNTX) Enterprise Value (2019 - 2026)
BioNTech SE's Enterprise Value came in at $9.88 billion for Q2 2026, down 49.6% from $19.58 billion a year earlier but up 20.9% from the prior quarter.
BioNTech SE (BNTX) Enterprise Value (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioNTech SE reported Enterprise Value of -$35.84 billion; for FY2025, it came in at $12.17 billion, up 55.1% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $7.85 billion in FY2024 (-54.1%), $17.08 billion in FY2023 (-22.2%), $21.96 billion in FY2022 (-64.4%) and $61.67 billion in FY2021 (+249.3%).
- The five-year range for quarterly Enterprise Value is $7.85 billion (Q4 2024) to $61.71 billion (Q4 2021).
- Year-over-year, Enterprise Value increased in three of the last eight quarters, with an average decline of 4.5%.
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2021 (growth of 356.4%), and the weakest in Q3 2022 (a decline of 67.9%).
- Business Quant data shows BNTX's Enterprise Value at $8.17 billion (Q1 2026), $12.17 billion (Q4 2025) and $17.01 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | BioNTech SE | 25.06 Bn | -34.31 Bn | 10.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.88 Bn |
| Mar 31, 2026 | 8.17 Bn |
| Dec 31, 2025 | 12.17 Bn |
| Sep 30, 2025 | 17.01 Bn |
| Jun 30, 2025 | 19.58 Bn |
| Mar 31, 2025 | 16.41 Bn |
| Dec 31, 2024 | 7.85 Bn |
| Sep 30, 2024 | 28.98 Bn |
| Jun 30, 2024 | 15.84 Bn |
| Mar 31, 2024 | 17.50 Bn |
| Dec 31, 2023 | 17.08 Bn |
| Sep 30, 2023 | 15.53 Bn |
| Jun 30, 2023 | 13.48 Bn |
| Mar 31, 2023 | 17.72 Bn |
| Dec 31, 2022 | 22.09 Bn |
| Sep 30, 2022 | 19.70 Bn |
| Jun 30, 2022 | 26.78 Bn |
| Mar 31, 2022 | 35.12 Bn |
| Dec 31, 2021 | 61.71 Bn |
| Sep 30, 2021 | 61.45 Bn |
BioNTech SE Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BNTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();